> top > docs > PubMed:32254064 > annotations

PubMed:32254064 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-OGER-BB

Id Subject Object Predicate Lexical cue
T1 27-33 UBERON:0001969 denotes plasma
T2 70-78 SP_7 denotes COVID-19
T3 80-127 SP_7 denotes Severe Acute Respiratory Syndrome Coronavirus 2
T4 93-104 UBERON:0001004 denotes Respiratory
T5 129-139 SP_7 denotes SARS-CoV-2
T6 155-166 NCBITaxon:11118 denotes coronavirus
T7 176-184 SP_7 denotes COVID-19
T8 311-321 SP_7 denotes SARS-CoV-2
T9 357-365 SP_7 denotes COVID-19
T10 396-402 UBERON:0001969 denotes plasma
T11 413-419 UBERON:0001969 denotes plasma
T12 443-454 NCBITaxon:1 denotes individuals
T13 509-519 GO:0042571 denotes antibodies
T14 529-537 GO:0042571 denotes antibody
T15 589-595 UBERON:0001969 denotes plasma
T16 679-690 NCBITaxon:1 denotes individuals
T17 740-746 UBERON:0001969 denotes plasma
T18 873-886 NCBITaxon:11118 denotes coronaviruses
T19 894-898 SP_10 denotes SARS
T20 894-900 PR:000014459 denotes SARS-1
T21 914-925 UBERON:0001004 denotes Respiratory
T22 936-940 SP_9 denotes MERS
T23 957-963 UBERON:0001969 denotes plasma
T24 990-998 SP_7 denotes COVID-19
T25 1107-1112 NCBITaxon:10239 denotes viral
T26 1152-1157 UBERON:0000178 denotes blood
T27 1260-1266 UBERON:0001969 denotes plasma
T28 1343-1353 GO:0065007 denotes regulatory
T29 1517-1523 UBERON:0001969 denotes plasma
T30 1745-1751 UBERON:0001969 denotes plasma
T31 1779-1789 GO:0065007 denotes regulatory

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T1 27-33 Body_part denotes plasma http://purl.org/sig/ont/fma/fma62970
T2 396-402 Body_part denotes plasma http://purl.org/sig/ont/fma/fma62970
T3 413-419 Body_part denotes plasma http://purl.org/sig/ont/fma/fma62970
T4 529-537 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T5 589-595 Body_part denotes plasma http://purl.org/sig/ont/fma/fma62970
T6 740-746 Body_part denotes plasma http://purl.org/sig/ont/fma/fma62970
T7 957-963 Body_part denotes plasma http://purl.org/sig/ont/fma/fma62970
T8 1152-1157 Body_part denotes blood http://purl.org/sig/ont/fma/fma9670
T9 1260-1266 Body_part denotes plasma http://purl.org/sig/ont/fma/fma62970
T10 1517-1523 Body_part denotes plasma http://purl.org/sig/ont/fma/fma62970
T11 1745-1751 Body_part denotes plasma http://purl.org/sig/ont/fma/fma62970

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 1152-1157 Body_part denotes blood http://purl.obolibrary.org/obo/UBERON_0000178
T2 1860-1865 Body_part denotes scale http://purl.obolibrary.org/obo/UBERON_0002542

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T1 70-78 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T2 80-127 Disease denotes Severe Acute Respiratory Syndrome Coronavirus 2 http://purl.obolibrary.org/obo/MONDO_0100096
T3 129-137 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T4 176-184 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T5 311-319 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T6 357-365 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T7 480-489 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T8 823-833 Disease denotes infectious http://purl.obolibrary.org/obo/MONDO_0005550
T9 894-898 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T10 990-998 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T1 27-33 http://purl.obolibrary.org/obo/UBERON_0001969 denotes plasma
T2 187-190 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T3 199-200 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T4 396-402 http://purl.obolibrary.org/obo/UBERON_0001969 denotes plasma
T5 413-419 http://purl.obolibrary.org/obo/UBERON_0001969 denotes plasma
T6 589-595 http://purl.obolibrary.org/obo/UBERON_0001969 denotes plasma
T7 740-746 http://purl.obolibrary.org/obo/UBERON_0001969 denotes plasma
T8 747-750 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T9 957-963 http://purl.obolibrary.org/obo/UBERON_0001969 denotes plasma
T10 964-967 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T11 1152-1157 http://purl.obolibrary.org/obo/UBERON_0000178 denotes blood
T12 1152-1157 http://www.ebi.ac.uk/efo/EFO_0000296 denotes blood
T13 1260-1266 http://purl.obolibrary.org/obo/UBERON_0001969 denotes plasma
T14 1517-1523 http://purl.obolibrary.org/obo/UBERON_0001969 denotes plasma
T15 1580-1591 http://purl.obolibrary.org/obo/BFO_0000030 denotes objectively
T16 1596-1597 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T17 1745-1751 http://purl.obolibrary.org/obo/UBERON_0001969 denotes plasma

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T1 1379-1384 Chemical denotes donor http://purl.obolibrary.org/obo/CHEBI_17891
T2 1398-1403 Chemical denotes donor http://purl.obolibrary.org/obo/CHEBI_17891

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
1 70-78 Disease denotes COVID-19 MESH:C000657245
15 80-127 Species denotes Severe Acute Respiratory Syndrome Coronavirus 2 Tax:2697049
16 129-139 Species denotes SARS-CoV-2 Tax:2697049
18 176-184 Disease denotes COVID-19 MESH:C000657245
19 311-321 Species denotes SARS-CoV-2 Tax:2697049
20 357-365 Disease denotes COVID-19 MESH:C000657245
21 480-489 Disease denotes infection MESH:D007239
22 823-842 Disease denotes infectious diseases MESH:D003141
23 873-886 Species denotes coronaviruses Tax:11118
24 902-934 Disease denotes Middle East Respiratory Syndrome MESH:D018352
25 936-940 Disease denotes MERS MESH:D018352
26 990-998 Disease denotes COVID-19 MESH:C000657245
27 1655-1662 Species denotes patient Tax:9606

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T1 0-79 Sentence denotes Deployment of convalescent plasma for the prevention and treatment of COVID-19.
T2 80-222 Sentence denotes Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the cause of coronavirus disease (COVID-19), has spurred a global health crisis.
T3 223-366 Sentence denotes To date, there are no proven options for prophylaxis for those who have been exposed to SARS-CoV-2, nor therapy for those who develop COVID-19.
T4 367-520 Sentence denotes Immune (i.e. "convalescent") plasma refers to plasma that is collected from individuals, following resolution of infection and development of antibodies.
T5 521-691 Sentence denotes Passive antibody administration through transfusion of convalescent plasma may offer the only short-term strategy to confer immediate immunity to susceptible individuals.
T6 692-943 Sentence denotes There are numerous examples, where convalescent plasma has been used successfully as post-exposure prophylaxis and/or treatment of infectious diseases, including other outbreaks of coronaviruses (e.g., SARS-1, Middle East Respiratory Syndrome [MERS]).
T7 944-1141 Sentence denotes Convalescent plasma has also been used in the COVID-19 pandemic; limited data from China suggest clinical benefit, including radiological resolution, reduction in viral loads and improved survival.
T8 1142-1294 Sentence denotes Globally, blood centers have robust infrastructure to undertake collections and construct inventories of convalescent plasma to meet the growing demand.
T9 1295-1452 Sentence denotes Nonetheless, there are nuanced challenges, both regulatory and logistical, spanning donor eligibility, donor recruitment, collections and transfusion itself.
T10 1453-1705 Sentence denotes Data from rigorously controlled clinical trials of convalescent plasma are also few, underscoring the need to evaluate its use objectively for a range of indications (e.g., prevention vs treatment) and patient populations (e.g., age, comorbid disease).
T11 1706-1927 Sentence denotes We provide an overview of convalescent plasma, from evidence of benefit, regulatory considerations, logistical work flow and proposed clinical trials, as scale up is brought underway to mobilize this critical resource.  .